electroCore, Inc.ECOR

$8.43-0.27 (-3.10%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$75M
Micro-cap
-83%
2018 — today
10-Year Price
-97%
2018 — today
52-Week Range
$4.31$10.35
Current $8.43· 68%

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Valuation in context

P/E ratio
-4.7
N/A
Not meaningful — company is unprofitable
P/B ratio
-13.3
N/A
Not meaningful — company is unprofitable
FCF Yield
-9.1%
Near historic high
Near historic highs — last 10 years
Free · No credit card needed

Get alerted when ECOR is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.